|
業務類別
|
Biotechnology |
|
業務概覽
|
Veradermics Inc clinical-stage biopharmaceutical company focused on developing therapeutics to address pervasive treatment challenges in prevalent aesthetic and dermatological conditions. The company operates in a single segment of allocating resources, assessing performance, and making operating decisions. |
| 公司地址
| 470 James Street, New Haven, CT, USA, 06513 |
| 電話號碼
| +1 228 372-3376 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.veradermics.com |
| 員工數量
| 21 |
| Mr. Mark Neumann |
Chief Commercial and Strategy Officer |
-- |
30/03/2026 |
| Mr. Reid Alexander Waldman, M.D. |
Chief Executive Officer and Director |
美元 450.00K |
30/03/2026 |
| Mr. Timothy August Durso, M.D. |
Chief Technical Officer |
美元 392.00K |
30/03/2026 |
| Mr. Dominic Gabriel Carrano, C.P.A. |
Chief Financial Officer |
美元 373.90K |
30/03/2026 |
| Mr. Michael V. Greco, J.D. |
General Counsel |
-- |
30/03/2026 |
|
|
| Mr. Patrick G. Enright, M.B.A. |
Independent Director |
30/03/2026 |
| Mr. John W. Childs |
Independent Director |
30/03/2026 |
| Dr. Vlad Coric, M.D. |
Independent Director |
30/03/2026 |
| Mr. Reid Alexander Waldman, M.D. |
Chief Executive Officer and Director |
30/03/2026 |
| Mr. David Matthew Friedman, M.D. |
Independent Director |
30/03/2026 |
| Mr. Jane M. Grant-Kels, M.D. |
Independent Director |
30/03/2026 |
| Ms. Katarina Pance, PhD |
Independent Director |
30/03/2026 |
|
|
|
|
